Galectin Therapeutics (GALT) Cash & Equivalents Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 67.78% |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | 89.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.75% |
| Dec 31, 2025 | 17.20% |
| Sep 30, 2025 | -57.41% |
| Jun 30, 2025 | -46.20% |
| Mar 31, 2025 | -68.45% |
| Sep 30, 2024 | 32.89% |
| Jun 30, 2024 | 42.48% |
| Mar 31, 2024 | 32.34% |
| Sep 30, 2023 | 28.62% |
| Jun 30, 2023 | -25.69% |
| Mar 31, 2023 | -43.68% |
| Sep 30, 2022 | -56.75% |
| Jun 30, 2022 | -23.48% |
| Mar 31, 2022 | 52.24% |
| Sep 30, 2021 | 12.42% |
| Jun 30, 2021 | -22.49% |
| Mar 31, 2021 | -52.09% |
| Dec 31, 2020 | -42.83% |
| Sep 30, 2020 | -35.32% |
| Jun 30, 2020 | -21.66% |
| Mar 31, 2020 | 521.46% |
| Dec 31, 2019 | 475.31% |
| Sep 30, 2019 | 396.62% |
| Jun 30, 2019 | 395.79% |
| Mar 31, 2019 | 74.82% |
| Dec 31, 2018 | 170.32% |
| Sep 30, 2018 | 45.67% |
| Jun 30, 2018 | 15.01% |
| Mar 31, 2018 | -70.77% |
| Dec 31, 2017 | -80.13% |
| Sep 30, 2017 | -56.67% |
| Jun 30, 2017 | -49.30% |
| Mar 31, 2017 | -38.97% |
| Dec 31, 2016 | -40.56% |
| Sep 30, 2016 | -24.67% |
| Jun 30, 2016 | -31.71% |
| Mar 31, 2016 | -23.83% |
| Dec 31, 2015 | -11.27% |
| Sep 30, 2015 | -31.67% |
| Jun 30, 2015 | -23.42% |
| Mar 31, 2015 | -19.80% |
| Dec 31, 2014 | 177.70% |
| Sep 30, 2014 | 221.16% |
| Jun 30, 2014 | 575.09% |
| Mar 31, 2014 | 421.43% |
| Dec 31, 2013 | 12.01% |
| Sep 30, 2013 | -12.15% |
| Jun 30, 2013 | -61.17% |
| Mar 31, 2013 | -54.17% |
| Dec 31, 2012 | 46.38% |
| Sep 30, 2012 | 39.21% |
| Jun 30, 2012 | 64.45% |
| Mar 31, 2012 | 120.41% |
| Dec 31, 2011 | 8.59% |
| Sep 30, 2011 | 182.30% |
| Jun 30, 2011 | 178.87% |